NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis

被引:23
作者
Licata, Anna [1 ]
Corrao, Salvatore [2 ]
Petta, Salvatore [1 ]
Genco, Chiara [1 ]
Cardillo, Mauro [2 ]
Calvaruso, Vincenza [1 ]
Cabibbo, Giuseppe [1 ]
Massenti, Fatima [3 ]
Camma, Calogero [1 ]
Licata, Giuseppe [2 ]
Craxi, Antonio [1 ]
机构
[1] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy
[2] Univ Palermo, Sez Med Interna & Cardioangiol, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy
[3] Univ Palermo, Dipartimento Sci Promoz Salute, Sez Igiene, Palermo, Italy
来源
PLOS ONE | 2013年 / 8卷 / 08期
关键词
BRAIN NATRIURETIC PEPTIDE; CARDIOMYOPATHY; DYSFUNCTION; RATS;
D O I
10.1371/journal.pone.0068364
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Aims: Plasma levels of NT-pro-BNP, a natriuretic peptide precursor, are raised in the presence of fluid retention of cardiac origin and can be used as markers of cardiac dysfunction. Recent studies showed high levels of NT pro BNP in patients with cirrhosis. We assessed NT pro-BNP and other parameters of cardiac dysfunction in patients with cirrhosis, with or without ascites, in order to determine whether the behaviour of NT pro BNP is linked to the stage of liver disease or to secondary cardiac dysfunction. Methods: Fifty eight consecutive hospitalized patients mostly with viral or NAFLD-related cirrhosis were studied. All underwent abdominal ultrasound and upper GI endoscopy. Cardiac morpho-functional changes were evaluated by echocardiography and NT-pro-BNP plasma levels determined upon admission. Twenty-eight hypertensive patients, without evidence of liver disease served as controls. Results: Fifty eight cirrhotic patients (72% men) with a median age of 62 years (11% with mild arterial hypertension and 31% with type 2 diabetes) had a normal renal function (mean creatinine 0.9 mg/dl, range 0.7-1.06). As compared to controls, cirrhotic patients had higher NT pro-BNP plasma levels (365.2 +/- 365.2 vs 70.8 +/- 70.6 pg/ml; p<0.001). Left atrial volume (LAV) (61.8 +/- 26.3 vs 43.5 +/- 14.1 ml; p = 0.001), and left ventricular ejection fraction (62.7 +/- 6.9 vs. 65.5 +/- 4%,; p = 0.05) were also altered in cirrhotic patients that in controls. Patients with F2-F3 oesophageal varices as compared to F0/F1, showed higher e' velocity (0.91 +/- 0.23 vs 0.66 +/- 0.19 m/s, p<0.001), and accordingly a higher E/A ratio (1.21 +/- 0.46 vs 0.89 +/- 0.33 m/s., p = 0.006). Conclusion: NT-pro-BNP plasma levels are increased proportionally to the stage of chronic liver disease. Advanced cirrhosis and high NT-pro-BNP levels are significantly associated to increased LAV and to signs of cardiac diastolic dysfunction. NT pro-BNP levels could hence be an useful prognostic indicators of early decompensation of cirrhosis.
引用
收藏
页数:7
相关论文
共 28 条
  • [1] Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms
    Bortoluzzi, Alessia
    Ceolotto, Giulio
    Gola, Elisabetta
    Sticca, Antonietta
    Bova, Sergio
    Morando, Filippo
    Piano, Salvatore
    Fasolato, Silvano
    Rosi, Silvia
    Gatta, Angelo
    Angeli, Paolo
    [J]. HEPATOLOGY, 2013, 57 (01) : 266 - 276
  • [2] 2-DIMENSIONAL ECHOCARDIOGRAPHIC EVALUATION OF LEFT-VENTRICULAR EJECTION FRACTION BY THE ELLIPSOID SINGLE-PLANE ALGORITHM - A RELIABLE METHOD FOR ASSESSING LOW OR VERY-LOW EJECTION FRACTION VALUES
    CORRAO, S
    PATERNA, S
    ARNONE, S
    COSTA, R
    AMATO, V
    AMICO, G
    SCAGLIONE, R
    LICATA, G
    [J]. CARDIOLOGY, 1995, 86 (06) : 503 - 507
  • [3] Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked α-tropomyosin mutations
    Coutu, P
    Bennett, CN
    Favre, EG
    Day, SM
    Metzger, JM
    [J]. CIRCULATION RESEARCH, 2004, 94 (09) : 1235 - 1241
  • [4] B-type natriuretic peptide in cardiovascular disease
    de Lemos, JA
    McGuire, DK
    Drazner, MH
    [J]. LANCET, 2003, 362 (9380) : 316 - 322
  • [5] Gavin JR, 2000, DIABETES CARE, V23, pS4
  • [6] Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis
    Giannini, E
    Botta, F
    Borro, P
    Risso, D
    Romagnoli, P
    Fasoli, A
    Mele, MR
    Testa, E
    Mansi, C
    Savarino, V
    Testa, R
    [J]. GUT, 2003, 52 (08) : 1200 - 1205
  • [7] Goetze JP, 2002, CLIN CHEM, V48, P1035
  • [8] American Society of Echocardiography recommendations for use of echocardiography in clinical trials - A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Echocardiography in Clinical Trials
    Gottdiener, JS
    Bednarz, J
    Devereux, R
    Gardin, J
    Klein, A
    Manning, WJ
    Morehead, A
    Kitzman, D
    Oh, J
    Quinones, M
    Schiller, NB
    Stein, JH
    Weissman, NJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2004, 17 (10) : 1086 - 1119
  • [9] Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease
    Henriksen, JH
    Gotze, JP
    Fuglsang, S
    Christensen, E
    Bendtsen, F
    Moller, S
    [J]. GUT, 2003, 52 (10) : 1511 - 1517
  • [10] The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule
    Iwakiri, Y
    Groszmann, RJ
    [J]. HEPATOLOGY, 2006, 43 (02) : S121 - S131